Skin nonmelanocytic tumor
Carcinoma (nonadnexal)
Squamous cell carcinoma


Topic Completed: 13 January 2020

Minor changes: 15 October 2020

Copyright: 2003-2020, PathologyOutlines.com, Inc.

PubMed Search: Squamous cell carcinoma[TI] skin[TI] review[ptyp]

Shaofeng Yan, M.D., Ph.D.
Page views in 2019: 51,127
Page views in 2020 to date: 44,067
Cite this page: Yan S. Squamous cell carcinoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/skintumornonmelanocyticscc.html. Accessed October 21st, 2020.
Definition / general
  • Cutaneous squamous cell carcinoma is a malignancy of epidermal keratinocytes that displays variable degrees of differentiation and cytological features
Essential features
  • Most patients have a favorable outcome after surgical resection
  • Only a subset of patients carry a higher risk of local recurrence, distant metastasis and mortality
  • Identifying and reporting the high risk features is important
Terminology
  • Cutaneous squamous cell carcinoma (cSCC)
  • Squamous cell carcinoma (SCC)
  • Squamous cell carcinoma in situ (SCCIS)
  • Bowen disease (BD)
ICD coding
  • ICD-O: 8070 / 3 - squamous cell carcinoma, NOS
Epidemiology
Sites
  • Most often in sun exposed areas
  • Scalp, ear, lip, nose, eyelid are high risk anatomic sites
Pathophysiology
  • Cutaneous squamous cell carcinoma appears to develop through a multistep process
  • UV radiation, mutations involving genes (such as TP53, CDKN2A, NOTCH1 and NOTCH2, EGFR and TERT) and molecular pathways (RAS / RAF / MEK / ERK and PI3K / AKT / mTOR) have been shown to play an important role in the pathogenesis (J Eur Acad Dermatol Venereol 2019 Nov 20 [Epub ahead of print])
Etiology
  • Ultraviolet light radiation and other forms of radiation
  • Chronic immunosuppressions
  • Actinic keratosis (precursor lesion), albinism (lack of pigmentation in skin), arsenic
  • Burn scars
  • Chronic ulcers
  • Chronic inflammation
  • Sinus tract
  • Human papillomavirus infection
  • Tars / oils
  • Xeroderma pigmentosa (J Am Acad Dermatol 2018;78:237)
Clinical features
  • Thin squamous cell carcinoma: erythematous scaly thin papule or plaque
  • Thicker tumors typically present as erythematous plaque, nodule, ulcer (Eur J Cancer 2015;51:1989)
Diagnosis
  • Characteristic gross features are suggestive of the diagnosis
  • Definitive diagnosis is made by shave, punch or excisional biopsies
Prognostic factors
Staging
  • Based on lesion size, depth of invasion, differentiation and perineural invasion
  • Helps to identify cutaneous squamous cell carcinomas with worse prognosis
  • 3 major staging methods (J Am Acad Dermatol 2019;80:106, JAMA Dermatol 2018;154:428)
    • AJCC, seventh edition of the American Joint Committee on Cancer (this staging system is not included in the eighth edition)
      • pT1: Tumor diameter < 2 cm, with < 2 high risk factors
      • pT2: Tumor diameter ≥ 2 cm or with ≥ 2 high risk factorsa
      • pT3: Tumor with invasion of maxilla, mandibular, orbit or temporal bone
      • pT4: Tumor with invasion of skeleton (axial or appendicular) or perineural invasion of skull base
      • aHigh risk factors: tumor thickness > 2 mm, Clark level IV / V, poor or undifferentiated, perineural invasion (PNI), location at ear or lip
    • AJCC, eighth edition of the American Joint Committee on Cancer for cutaneous squamous cell carcinoma of the head and neck
      • pT1: Tumor diameter ≤ 2 cm
      • pT2: Tumor diameter ≥ 2 cm and < 4 cm
      • pT3: Tumor with diameter ≥ 4 cm or with one of the high risk featuresb
      • pT4a: Tumor with gross cortical bone / marrow invasion of maxilla, mandibular orbit or temporal bone
      • pT4b: Tumor with skull base invasion or skull base foramen involvement
      • bHigh risk features: perineural invasion (of a nerve lying beneath the dermis or ≥ 0.1 mm in caliber or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression), deep invasion (involvement beyond the subcutaneous fat or > 6 mm) and minor bone erosion
    • Brigham and Women's Hospital (BWH) classification
      • pT1: 0 high risk factorsc
      • pT2a: 1 high risk factor
      • pT2b: 2 - 3 high risk factors
      • pT3: ≥ 4 high risk factors or bone invasion
      • cHigh risk factors: tumor diameter ≥ 2 cm, poorly differentiated, perineural invasion ≥ 0.1 mm or tumor invasion beyond fat
Case reports
Treatment
Clinical images

Images hosted on other servers:

Scalp mass

Exophytic mass

Inoperable tumor

Gross description
Microscopic (histologic) description
  • Carcinoma of keratinocytes that infiltrates the dermis
  • An associated precursor lesion (actinic keratosis / keratinocytic dysplasia / squamous cell carcinoma in situ) is often present
  • Spectrum of histologic features; all share downward growth below level of adjacent or overlying epidermis
  • Grading based on degree of differentiation and keratinization (J Am Acad Dermatol 2018;78:237)
    • Well differentiated: easily recognizable squamous epithelium, abundant keratinization, intercellular bridges apparent, minimal pleomorphism, mitotic figures basally located
    • Moderately differentiated: focal keratinization; features between well and poorly differentiated
    • Poorly differentiated: no / minimal keratinization, marked nuclear atypia, may be difficult to establish squamous differentiation
    • Undifferentiated: no keratinization, immunohistochemistry is usually necessary to confirm the diagnosis and to exclude melanoma or sarcoma
  • Histologic patterns (Hematol Oncol Clin North Am 2019;33:1)
    • Low risk histologic variants
      • Keratoacanthoma: well differentiated, crateriform appearance
      • Verrucous carcinoma: verruciform surface, blunt endophytic growth, minimal atypia
      • Clear cell squamous cell carcinoma: > 25% cells with cytoplasmic clearing (glycogen accumulation or hydropic degeneration)
    • High risk histologic variants
      • Acantholytic: squamous cell carcinoma with acantholysis, pseudoglandular (CEA negative)
        • Acantholysis is the loss of cell to cell connections between keratinocytes, resulting in loss of intercellular cohesion
      • Invasive Bowen disease: invasive islands of squamous and basaloid cells with overlying classic Bowen disease
      • Spindle cell squamous cell carcinoma: commonly associated with a good prognosis, less often associated with a poor prognosis following exposure to ionizing radiation, trauma or burn
      • Desmoplastic squamous cell carcinoma: poorly differentiated, pleomorphic spindle cells with a dense stromal response
      • Adenosquamous carcinoma: mixed squamous and glandular differentiation (CEA positive)
    • Uncommon variants
      • Lymphoepitheliomatous
      • Pseudovascular squamous cell carcinoma
      • Squamous cell carcinoma with sarcomatoid differentiation
      • Squamous cell carcinoma with osteoclast-like cells
Microscopic (histologic) images

Contributed by Shaofeng Yan, M.D., Ph.D.

Invasive SCC

Well differentiated SCC

Moderately differentiated SCC

Poorly differentiated SCC

Keratoacanthoma type SCC

Acantholytic SCC


Bowenoid SCC

SCC with sarcomatoid differentiation

SCC with sarcomatoid differentiation: CK5

Perineural invasion

Perineural invasion: S100 / CK5 double stain



Contributed by Semir Vranić, M.D., Ph.D.

Acantholytic type

Cytology images

Images hosted on other servers:

Papanicolaou and Romanowsky

Positive stains
Sample pathology report
  • Skin, left temple, shave biopsy:
    • Invasive squamous cell carcinoma, well differentiated, present at the peripheral and deep specimen edges
  • 
Skin, left temple, excision:
    • Invasive squamous cell carcinoma, poorly differentiated, present at the peripheral specimen margin (see synoptic report)
Differential diagnosis
  • Inflammatory dermatoses:
    • Hypertrophic lupus erythematosus, lichen planus:
      • Both can mimic due to marked squamous hyperplasia particularly if clinical information is not available
      • Absence of infiltrating squamous epithelium, presence of multiple lesions and features of lupus erythematosus (such as vacuolar interface lymphocytic infiltrate, necrotic keratinocytes, increase of dermal mucin, superficial and deep perivascular and periadnexal lymphocytic infiltrate) or lichen planus (such as wedge shaped hypergranulosis, band-like lymphocytic infiltrate with colloid bodies) are key differentiators
  • Miscellaneous keratoses:
    • Proliferative actinic keratosis:
      • Epithelial dysplasia variable from mild basal layer changes to carcinoma in situ and often associated with solar elastosis and parakeratosis
      • Budding of atypical epithelium into the papillary dermis
      • Distinction from early invasive squamous cell carcinoma is somewhat artificial, the presence of single or groups of atypical keratinocytes detached from the main lesion or associated with a stromal reaction supports invasive squamous cell carcinoma
    • Inverted follicular keratosis, clonal seborrheic keratosis:
      • Intradermal or inverted type of seborrheic keratosis is known as inverted follicular keratosis and is characterized by intradermal whorls of maturing squamous epithelium, so called squamous eddies
      • Sometimes, intraepithelial nesting gives rise to the intraepidermal epitheliomatous (Borst-Jadassohn) nodular appearance, surrounded by normal basaloid cells; this is also called clonal seborrheic keratosis
  • Other malignant tumors:
    • Basal cell carcinoma:
      • Frequently originates from the overlying and consists of small basaloid cells with peripheral palisading, darkly staining nuclei and minimal cytoplasm
      • Intercellular bridges are not as evident
      • Mitoses and apoptosis are commonly present
    • Adnexal carcinoma:
      • Eccrine porocarcinoma may show bowenoid features
      • Microcystic adnexal carcinoma may mimic keratinizing squamous cell carcinoma, especially in superficial biopsies in which ductal structures are not obvious
        • Identification of ductal differentiation by EMA or CEA is helpful
    • Malignant melanoma, sarcoma, lymphoma:
      • Adequate sampling to detect an epithelial origin or a junctional component is important
      • Cytokeratin, SOX10, CD45 or desmin will usually enable distinction from melanoma, lymphoma, sarcoma (or leiomyosarcoma)
      • p63 or p40 are usually negative in atypical fibroxanthoma or undifferentiated pleomorphic sarcoma
  • Pseudoepitheliomatous hyperplasia:
    • After trauma, surgery, infection; may be associated with granular cell tumor
    • Can be seen in association with chronic healing wounds, chronic irritation and infection
    • Benign and reactive epidermal acanthosis showing irregular and often endophytic growth pattern
    • Prominent acanthotic downgrowths and keratinocytes with bland nuclear features containing abundant cytoplasm
Board review style question #1
Which subtype of cutaneous squamous cell carcinoma is shown in the image below?



  1. Acantholytic type
  2. Adenosquamous type
  3. Desmoplastic type
  4. Keratoacanthoma type
Board review answer #1
A. Acantholytic type

Comment Here

Reference: Squamous cell carcinoma
Board review style question #2
Which of the following is a good prognostic factor for cutaneous squamous cell carcinoma?

  1. Desmoplastic type squamous cell carcinoma
  2. Keratoacanthoma type squamous cell carcinoma
  3. Tumor invades beyond subcutaneous fat
  4. Tumor size > 2 cm
Board review answer #2
B. Keratoacanthoma type squamous cell carcinoma

Comment Here

Reference: Squamous cell carcinoma
Back to top
Image 01 Image 02